Cargando…

Clinical features, therapeutic outcomes, and recovery period of long COVID

To characterize the clinical features of long COVID, 286 patients who received care in our outpatient clinic for long COVID from May to December 2021 were surveyed. The recovery periods of each symptom and the key factors contributing to early recovery were statistically analysed. The median age of...

Descripción completa

Detalles Bibliográficos
Autores principales: Takakura, Kazuki, Suka, Machi, Kajihara, Mikio, Koido, Shigeo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108287/
https://www.ncbi.nlm.nih.gov/pubmed/36412057
http://dx.doi.org/10.1002/jmv.28316
_version_ 1785026820130734080
author Takakura, Kazuki
Suka, Machi
Kajihara, Mikio
Koido, Shigeo
author_facet Takakura, Kazuki
Suka, Machi
Kajihara, Mikio
Koido, Shigeo
author_sort Takakura, Kazuki
collection PubMed
description To characterize the clinical features of long COVID, 286 patients who received care in our outpatient clinic for long COVID from May to December 2021 were surveyed. The recovery periods of each symptom and the key factors contributing to early recovery were statistically analysed. The median age of the patients was 35.8 years, with 137 men and 149 women. The median number of symptoms was 2.8. The most frequent symptoms were respiratory manifestations (52.1%), followed by fatigue (51.4%). Respiratory symptoms, fatigue, and headache/arthralgia were major complaints in the initial phase, whereas hair loss was a major complaint in the late phase, suggesting that the chief complaint of patients with long COVID may vary temporally. The best treatment outcome was observed for pulmonary symptoms, and hair loss had the worst outcome. COVID‐19 severity, the number of manifestations, and the delay in starting treatment exerted a negative effect on the recovery period of long COVID. In addition, the smoking habit was an independent risk factor for slowing the recovery period from long COVID. This study provides insights into the clinical course of each manifestation and therapeutic options with a more certain future of long COVID to meet the unmet medical needs.
format Online
Article
Text
id pubmed-10108287
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-101082872023-04-18 Clinical features, therapeutic outcomes, and recovery period of long COVID Takakura, Kazuki Suka, Machi Kajihara, Mikio Koido, Shigeo J Med Virol Research Articles To characterize the clinical features of long COVID, 286 patients who received care in our outpatient clinic for long COVID from May to December 2021 were surveyed. The recovery periods of each symptom and the key factors contributing to early recovery were statistically analysed. The median age of the patients was 35.8 years, with 137 men and 149 women. The median number of symptoms was 2.8. The most frequent symptoms were respiratory manifestations (52.1%), followed by fatigue (51.4%). Respiratory symptoms, fatigue, and headache/arthralgia were major complaints in the initial phase, whereas hair loss was a major complaint in the late phase, suggesting that the chief complaint of patients with long COVID may vary temporally. The best treatment outcome was observed for pulmonary symptoms, and hair loss had the worst outcome. COVID‐19 severity, the number of manifestations, and the delay in starting treatment exerted a negative effect on the recovery period of long COVID. In addition, the smoking habit was an independent risk factor for slowing the recovery period from long COVID. This study provides insights into the clinical course of each manifestation and therapeutic options with a more certain future of long COVID to meet the unmet medical needs. John Wiley and Sons Inc. 2022-12-02 2023-01 /pmc/articles/PMC10108287/ /pubmed/36412057 http://dx.doi.org/10.1002/jmv.28316 Text en © 2022 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Takakura, Kazuki
Suka, Machi
Kajihara, Mikio
Koido, Shigeo
Clinical features, therapeutic outcomes, and recovery period of long COVID
title Clinical features, therapeutic outcomes, and recovery period of long COVID
title_full Clinical features, therapeutic outcomes, and recovery period of long COVID
title_fullStr Clinical features, therapeutic outcomes, and recovery period of long COVID
title_full_unstemmed Clinical features, therapeutic outcomes, and recovery period of long COVID
title_short Clinical features, therapeutic outcomes, and recovery period of long COVID
title_sort clinical features, therapeutic outcomes, and recovery period of long covid
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108287/
https://www.ncbi.nlm.nih.gov/pubmed/36412057
http://dx.doi.org/10.1002/jmv.28316
work_keys_str_mv AT takakurakazuki clinicalfeaturestherapeuticoutcomesandrecoveryperiodoflongcovid
AT sukamachi clinicalfeaturestherapeuticoutcomesandrecoveryperiodoflongcovid
AT kajiharamikio clinicalfeaturestherapeuticoutcomesandrecoveryperiodoflongcovid
AT koidoshigeo clinicalfeaturestherapeuticoutcomesandrecoveryperiodoflongcovid